HPC — Hydration Pharmaceuticals Co Cashflow Statement
0.000.00%
Last trade - 00:00- AU$1.72m
- AU$0.14m
- $2.47m
Annual cashflow statement for Hydration Pharmaceuticals Co, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | -8.08 | -9.75 | -5.73 | -3.88 | -3.65 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -8.08 | -9.75 | -5.73 | -3.88 | -3.65 |
| Capital Expenditures | 0 | — | — | — | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0 | 0 | — | 9.44 | 0 |
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 0 | 0 | — | 9.44 | 0 |
| Financing Cash Flow Items | -1.42 | 0 | -0.241 | -0.024 | 0 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 17 | 4.08 | 2.72 | -4.07 | 0.806 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 9.03 | -5.98 | -2.85 | 1.38 | -2.1 |